investment.com
EQUITIES

Aquestive Therapeutics, Inc. · AQST

Explore the company behind the ticker: reported financials, public filings and connected disclosures.

QUOTE COVERAGE

No quote recorded

licensed executable quote only; no value is inferred when the feed is absent

Explore companies ↗
THE BUSINESS IN NUMBERS

Reported financials

Full financials ↗
Revenue44.55MFY 2025 · USD2022: 47,680,000.00 · 2025: 44,545,000.00
Net income-83.78MFY 2025 · USD2022: -54,410,000.00 · 2025: -83,784,000.00
Total assets160.43MFY 2025 · USD2022: 57,070,000.00 · 2025: 160,425,000.00
Cash & equivalents121.17MFY 2025 · USD2022: 27,273,000.00 · 2025: 121,169,000.00

SEC-reported annual figures. Revenue change: −22.61%. Units follow the original filing; these are reported financials, not a stock quote.